UPDATED: After refuting a supposed data leak as 'falsified', Olema reveals first clinical data for lead program — shares crash
Olema Oncology had been preparing to present the first clinical data from its lead program at a conference next week, but the biotech’s poster supposedly leaked online Monday. In response, Olema issued a statement saying the image was falsified, and published topline results in a press release Tuesday morning.
The leaked poster ostensibly came from a patient in the Phase I portion of the study, who posted on a discussion forum after saying they completed treatment and received a summary. Originally written on the advocacy website Inspire.com, the forum now leads to a 404 page, but some social media users managed to screenshot the post.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,500+ biopharma pros reading Endpoints daily — and it's free.